Bharat Parenterals Shareholders Approve Preferential Issue and Enhanced Investment Limits
Bharat Parenterals Ltd 路 Others (Uncategorized) 路 24 Oct 2026, 11:13 pm
Bharat Parenterals Shareholders Approve Preferential Issue and Enhanced Investment Limits Bharat Parenterals Limited announced that shareholders approved two special resolutions with 100% majority at its EGM held on 23rd Oct'26. The approved measures include the issuance of equity shares on a preferential basis and authorization to make investments, extend loans, give guarantees, and provide securities exceeding limits under Section 186(2) of the Companies Act, 2013. A total of 4,879,194 votes were cast via remote e-voting across 69 members, representing 70.80% of total voting rights, with zero dissenting or invalid votes recorded.
Original exchange filing (PDF)
More announcements from Bharat Parenterals Ltd
- Intimation for receipt of Establishment Inspection Report from US FDA by Innoxel Lifesciences Pvt Ltd., a subsidiary company of Bharat Parenterals Limited. 路 05 Nov 2026
- Transcript of Earnings Conference Call of Q2FY27. 路 02 Nov 2026
- Audio Recording of Q2FY27 Earnings Conference Call. 路 30 Oct 2026
- Investor Presentation for the Quarter and Half Year ended on September 30, 2026. 路 29 Oct 2026
- Un-Audited Standalone and Consolidated Financial Results For the Quarter and Half Year Ended On September 30, 2026. 路 29 Oct 2026
- Outcome of the Meeting of the Board of Director of Bharat Parenterals Limited held on October 29, 2026 路 29 Oct 2026
- Approval of Preferential Issue by Shareholders of the Company through EGM Held on October 23, 2026. 路 25 Oct 2026
- Revised Voting Result 路 25 Oct 2026
